Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
524.00    4.00 (0.77%)
Bid:
524.00
Ask:
528.00
Spread: 4.00 (0.763%)
Market Cap: £867.04m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Trading Update

6 Feb 2014 07:00

RNS Number : 4124Z
Oakley Capital Investments Limited
06 February 2014
Β 

ο»Ώ

06 February 2014

Β 

Oakley Capital Investments Limited ("OCIL" or the "Company")

Β 

Trading Update for the 12 months ended 31 December 2013

Β 

o NAV per share (unaudited) expected to be in the range of Β£1.98 - Β£2.00, representing an increase of over 9% from the prior year (31 December 2012: Β£1.81)

o Four realisations in the period achieving a gross money multiple of 2.8x and an IRR of 43%, and returning Β£33 million to the Company

o Acquired control of Reddam House, a leading operator of independent schools, with a view to international expansion

Β 

Oakley Capital Investments Limited (AIM: OCL), the AIM-listed company established to provide investors with access to the investment strategy being pursued by Oakley Capital Private Equity L.P. (the "Limited Partnership") and its successor funds, today announces a trading update for the 12 months ended 31 December 2013.

Β 

The Company, through its investment in the Limited Partnership, has an indirect interest in each of the Limited Partnership's portfolio companies representing 65% of the Limited Partnership's total commitments.

Β 

The Limited Partnership's portfolio of investments comprises six businesses; Daisy Group plc; Verivox Holdings Limited; Time Out Limited and Time Out America LLC (together, "Time Out Group"); intergenia Holding GmbH; Broadstone Pensions and Investments Limited; and Educas Investments LLP ("Educas"). Oakley Capital Limited, OCIL's investment adviser, estimates that the Company's net asset value, which is subject to the completion of the 31 December 2013 audit of the Limited Partnership, and the Company, will be in the range of Β£245 million to Β£247 million, generating a net asset value per share of Β£1.98 to Β£2.00 (31 December 2012: Β£1.81). The OCIL net asset value is made up of cash, the investment in the Limited Partnership, short-term bridging finance for the Limited Partnership and loans provided to a number of the portfolio companies.

Β 

Key Highlights

Β 

Of the four realisations in the period, two were significant:

Β 

Β· On 31 January 2013, the Limited Partnership sold Emesa B.V. to Cyrte Investments B.V. for gross consideration of €95 million. This represented a 3.5x return on investment for the Limited Partnership and a gross IRR in excess of 100%. As a result of the disposal, Β£25.6 million was distributed to the Company.

Β 

Β· On 10 May 2013, the Limited Partnership sold Headland Media Limited to KVH Industries, Inc for an enterprise value of Β£15.5 million, representing a 2.7x return on investment for the Limited Partnership and a gross IRR of 27%. As a result of the disposal, Β£6.6 million was distributed to the Company.

Β 

On 10 July 2013, the Limited Partnership used Educas to acquire control of Reddam House, a leading operator of premium private schools in South Africa, for €16.8 million, providing a significant growth opportunity, including the potential to explore international acquisitions leveraging Reddam House's excellent reputation in the independent schools' sector.

Β 

Peter Dubens, Director, commented:

Β 

"2013 has been a year of very significant progress for OCIL with NAV per share up over 9% year on year based on strong exits made by the Limited Partnership and the underlying financial performance of the remainder of the investment portfolio. 2014 has started strongly with an interesting pipeline of proprietary investment opportunities under consideration."

Β 

Β 

For further information please contact:

Β 

Oakley Capital Investments Limited

+44 20 7766 6900

Peter Dubens

Β 

FTI Consulting

+44 20 7831 3113

Edward Bridges

Β 

Liberum Capital Limited (Nominated Adviser & Broker)

+44 20 3100 2000

Steve Pearce / Tom Fyson

Β 

Β 

About Oakley Capital Investments Limited ("OCIL")

Oakley Capital Investments Limited is a Bermudan based company listed on AIM. OCIL seeks to

provide investors with long term capital appreciation through its investments in Oakley Capital Private Equity L.P. and OCPE II Master L.P. and, over time, through co-investment opportunities.

Β 

About Oakley Capital Private Equity L.P. and OCPE II Master L.P.

Oakley Capital Private Equity L.P. and its successor fund, OCPE II Master L.P., are both unlisted UK and European mid-market private equity funds with the aim of providing investors with significant long term capital appreciation. The investment strategy of both funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement. Both funds seek to invest in companies with scale in their industry subsectors, thereby creating a sustainable earnings stream which should command a premium on exit.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTSSMFAIFLSEDE
Date   Source Headline
4th Mar 20247:00 amRNSNotice of Results and Investor Presentation
15th Feb 20247:00 amRNSAppointment of Financial Adviser
13th Feb 20247:00 amRNSDirector Dealing
13th Feb 20247:00 amRNSDirector Dealing
24th Jan 20247:00 amRNSTrading Statement
16th Jan 20247:00 amRNSOakley agrees investment in Steer Automotive Group
15th Jan 20247:00 amRNSHolding(s) in Company
29th Dec 20237:00 amRNSSettlement of Fund I Loan
20th Dec 20239:39 amRNSUpdate from QuotedData
20th Dec 20237:00 amRNSHolding(s) in Company
28th Nov 20232:39 pmRNSResult of AGM
21st Nov 20237:00 amRNSDirector Dealing
7th Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
2nd Nov 20237:00 amRNSDirector Dealing
30th Oct 20237:00 amRNSNotice of AGM and Directorate Change
30th Oct 20237:00 amRNSInvestment in Alerce
26th Oct 202311:14 amRNSInvestment in Webcentral
25th Oct 20237:00 amRNSTrading update for the 3 months ended 30 Sep 2023
18th Oct 20237:00 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSHolding(s) in Company
14th Sep 20235:53 pmRNSInterim Results 2023 - Replacement
14th Sep 20237:00 amRNSInterim Results for the 6 months ended 30 June 23
30th Aug 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSOakley invests in three dental labs businesses
31st Jul 202312:14 pmRNSDirector Dealing
28th Jul 20232:27 pmRNSDirector Dealing
26th Jul 20237:00 amRNSTrading update for the 6 months ended 30 June 2023
26th Jun 20237:00 amRNSDirector Dealing
26th Jun 20237:00 amRNSDirector Dealing
19th Jun 202311:44 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
22nd May 202310:51 amRNSDirector Dealing
17th May 20238:04 amRNSOakley Capital extends IU Group partnership
10th May 20237:00 amRNSSale and Reinvestment in IU Group
26th Apr 20237:00 amRNSTrading update for the 3 months ended 31 Mar 2023
18th Apr 20237:00 amRNSOakley partners with schools group Thomas's
4th Apr 20231:13 pmRNSInitiation from QuotedData
31st Mar 20238:00 amEQSHardman & Co Q&A on Oakley Capital Investments (OCI): 2022 Results: EBITDA Growth Drives NAV Appreciation
16th Mar 20237:00 amRNSDirector Dealing
15th Mar 20237:15 amEQSHardman & Co Research on Oakley Capital Investments Ltd (OCI): 2022: NAV returns driven by EBITDA growth
9th Mar 20237:00 amRNSFinal Results for the Year Ended 31 December 2022
27th Feb 20237:00 amRNSNotice of Results and Investor Presentation
25th Jan 20237:00 amRNSTrading update for the year ended 31 December 2022
18th Jan 20234:19 pmRNSHolding(s) in Company
18th Jan 20234:19 pmRNSHolding(s) in Company
18th Jan 20232:15 pmEQSHardman & Co Q&A on Oakley Capital Investments Ltd (OCI): High-growth drivers in 2023
15th Dec 20227:00 amRNSOCI commits EUR 30m to Oakley PROfounders III
29th Nov 20227:30 amEQSHardman & Co Research on Oakley Capital Investments Ltd (OCI): Evolution of the high-growth drivers in 2023
10th Nov 20224:17 pmRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.